101 related articles for article (PubMed ID: 35585988)
1. pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury.
Chen MC; Lai KS; Chien KL; Teng ST; Lin YR; Chao W; Lee MJ; Wei PL; Huang YH; Kuo HP; Weng CM; Chou CL
Front Immunol; 2022; 13():871828. PubMed ID: 35585988
[TBL] [Abstract][Full Text] [Related]
2. The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.
Adas G; Cukurova Z; Yasar KK; Yilmaz R; Isiksacan N; Kasapoglu P; Yesilbag Z; Koyuncu ID; Karaoz E
Cell Transplant; 2021; 30():9636897211024942. PubMed ID: 34180719
[TBL] [Abstract][Full Text] [Related]
3. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS).
Hashemian SM; Shafigh N; Afzal G; Jamaati H; Tabarsi P; Marjani M; Malekmohammad M; Mortazavi SM; Khoundabi B; Mansouri D; Moniri A; Hajifathali A; Roshandel E; Mortaz E; Adcock IM
Pulmonology; 2021; 27(6):486-492. PubMed ID: 33358260
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab for severe COVID-19 related illness - A community academic medical center experience.
Meleveedu KS; Miskovsky J; Meharg J; Abdelrahman A; Tandon R; Moody AE; Dasilva P; Masse G; LaPorte J; Saied Calvino A; Allen G; El-Bizri R; Roberts T; Armenio V; Katz SC
Cytokine X; 2020 Dec; 2(4):100035. PubMed ID: 32895645
[TBL] [Abstract][Full Text] [Related]
5. Machine learning of flow cytometry data reveals the delayed innate immune responses correlate with the severity of COVID-19.
Zhu J; Chen T; Mao X; Fang Y; Sun H; Wei DQ; Ji G
Front Immunol; 2023; 14():974343. PubMed ID: 36845115
[TBL] [Abstract][Full Text] [Related]
6. Cell type-specific immune dysregulation in severely ill COVID-19 patients.
Yao C; Bora SA; Parimon T; Zaman T; Friedman OA; Palatinus JA; Surapaneni NS; Matusov YP; Chiang GC; Kassar AG; Patel N; Green CE; Aziz AW; Suri H; Suda J; Lopez AA; Martins GA; Stripp BR; Gharib SA; Goodridge HS; Chen P
medRxiv; 2020 Jul; ():. PubMed ID: 32743611
[TBL] [Abstract][Full Text] [Related]
7. Dynamic changes in radiological parameters, immune cells, selected miRNAs, and cytokine levels in peripheral blood of patients with severe COVID‑19.
Bukreieva T; Kyryk V; Nikulina V; Svitina H; Vega A; Chybisov O; Shablii I; Mankovska O; Lobyntseva G; Nemtinov P; Skrypkina I; Shablii V
Biomed Rep; 2023 May; 18(5):33. PubMed ID: 37034572
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated Host Response in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Critical Illness.
Tiwari-Heckler S; Rauber C; Longhi MS; Zörnig I; Schnitzler P; Jäger D; Giese T; Merle U
Open Forum Infect Dis; 2021 Mar; 8(3):ofab019. PubMed ID: 33778090
[TBL] [Abstract][Full Text] [Related]
9. The Evolution of Blood Cell Phenotypes, Intracellular and Plasma Cytokines and Morphological Changes in Critically Ill COVID-19 Patients.
Berghäll E; Hultström M; Frithiof R; Lipcsey M; Hahn-Strömberg V
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625671
[TBL] [Abstract][Full Text] [Related]
10. Bifurcated monocyte states are predictive of mortality in severe COVID-19.
Cillo AR; Somasundaram A; Shan F; Cardello C; Workman CJ; Kitsios GD; Ruffin A; Kunning S; Lampenfeld C; Onkar S; Grebinoski S; Deshmukh G; Methe B; Liu C; Nambulli S; Andrews L; Duprex WP; Joglekar AV; Benos PV; Ray P; Ray A; McVerry BJ; Zhang Y; Lee JS; Das J; Singh H; Morris A; Bruno TC; Vignali DAA
bioRxiv; 2021 Feb; ():. PubMed ID: 33594364
[TBL] [Abstract][Full Text] [Related]
11. Single-cell transcriptomic analysis reveals a systemic immune dysregulation in COVID-19-associated pediatric encephalopathy.
Wang Y; Luu LDW; Liu S; Zhu X; Huang S; Li F; Huang X; Guo L; Zhang J; Ge H; Sun Y; Hui Y; Qu Y; Wang H; Wang X; Na W; Zhou J; Qu D; Tai J
Signal Transduct Target Ther; 2023 Oct; 8(1):398. PubMed ID: 37848421
[TBL] [Abstract][Full Text] [Related]
12. Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19.
Neumann J; Prezzemolo T; Vanderbeke L; Roca CP; Gerbaux M; Janssens S; Willemsen M; Burton O; Van Mol P; Van Herck Y; ; Wauters J; Wauters E; Liston A; Humblet-Baron S
Clin Transl Immunology; 2020; 9(11):e1204. PubMed ID: 33209300
[TBL] [Abstract][Full Text] [Related]
13. Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNFα-antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure.
Hachem H; Godara A; Schroeder C; Fein D; Mann H; Lawlor C; Marshall J; Klein A; Poutsiaka D; Breeze JL; Joshi R; Mathew P
J Clin Transl Sci; 2021; 5(1):e146. PubMed ID: 34457357
[TBL] [Abstract][Full Text] [Related]
14. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.
Wen W; Su W; Tang H; Le W; Zhang X; Zheng Y; Liu X; Xie L; Li J; Ye J; Dong L; Cui X; Miao Y; Wang D; Dong J; Xiao C; Chen W; Wang H
Cell Discov; 2020; 6():31. PubMed ID: 32377375
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the Leukocyte Signaling Landscape during Acute COVID-19.
Turnbull IR; Fuchs A; Remy KE; Kelly MP; Frazier EP; Ghosh S; Chang SW; Mazer M; Hess A; Leonard J; Hoofnagle M; Colonna M; Hotchkiss RS
Res Sq; 2021 Feb; ():. PubMed ID: 33619472
[TBL] [Abstract][Full Text] [Related]
16. Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participants.
Gygi JP; Maguire C; Patel RK; Shinde P; Konstorum A; Shannon CP; Xu L; Hoch A; Jayavelu ND; Network I; Haddad EK; Reed EF; Kraft M; McComsey GA; Metcalf J; Ozonoff A; Esserman D; Cairns CB; Rouphael N; Bosinger SE; Kim-Schulze S; Krammer F; Rosen LB; van Bakel H; Wilson M; Eckalbar W; Maecker H; Langelier CR; Steen H; Altman MC; Montgomery RR; Levy O; Melamed E; Pulendran B; Diray-Arce J; Smolen KK; Fragiadakis GK; Becker PM; Augustine AD; Sekaly RP; Ehrlich LIR; Fourati S; Peters B; Kleinstein SH; Guan L
bioRxiv; 2023 Nov; ():. PubMed ID: 37986828
[TBL] [Abstract][Full Text] [Related]
17. Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction.
Rouhani SJ; Trujillo JA; Pyzer AR; Yu J; Fessler J; Cabanov A; Higgs EF; Cron KR; Zha Y; Lu Y; Bloodworth JC; Abasiyanik MF; Okrah S; Flood BA; Hatogai K; Leung MY; Pezeshk A; Kozloff L; Reschke R; Strohbehn GW; Chervin CS; Kumar M; Schrantz S; Madariaga ML; Beavis KG; Yeo KJ; Sweis RF; Segal J; Tay S; Izumchenko E; Mueller J; Chen LS; Gajewski TF
Res Sq; 2021 Nov; ():. PubMed ID: 34845442
[TBL] [Abstract][Full Text] [Related]
18. Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19.
Neyton LPA; Patel RK; Sarma A; ; Willmore A; Haller SC; Kangelaris KN; Eckalbar WL; Erle DJ; Krummel MF; Hendrickson CM; Woodruff PG; Langelier CR; Calfee CS; Fragiadakis GK
Res Sq; 2023 Aug; ():. PubMed ID: 37577607
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment.
Fang Y; Lao P; Tang L; Chen J; Chen Y; Sun L; Tan W; Fan X
Cell Transplant; 2023; 32():9636897231184611. PubMed ID: 37395459
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cell and macrophage crosstalk in acute lung injury: future perspectives.
Guan T; Zhou X; Zhou W; Lin H
Cell Death Discov; 2023 Jan; 9(1):9. PubMed ID: 36646692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
